Improving patient engagement in collaborative care for anxiety and depression
Official title: Enhancing Engagement by Integrating Goals and Concerns That Matter to Patients
Run by Dartmouth-Hitchcock Medical Center · NCT06898593 · Data updated 2026-11-12
This study is testing a new way to involve patients more in their anxiety and depression treatment by using their personal goals to see if it makes them and their doctors happier with the care they receive.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 2448 (estimated) |
| Sponsor | Dartmouth-Hitchcock Medical Center Academic / other |
| Locations | 6 sites (Concord, New Hampshire and 5 other locations) |
| Status | Recruiting |
| Started | April 2, 2025 |
| Main results expected | July 31, 2027 |
| Study ends | July 31, 2028 |
| Registry record updated | July 22, 2026 |
| Trial ID | NCT06898593 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults enrolled in the Collaborative Care Model at Dartmouth Health who are experiencing anxiety or depression.
✕Probably not a fit
Patients not enrolled in the Collaborative Care Model at Dartmouth Health will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to enhance patient engagement in the Collaborative Care Model (CoCM) for anxiety and depression by integrating patients' personal goals and concerns into the treatment process. Participants will complete pre-visit questionnaires that will be used to create a visual dashboard for clinicians, allowing for a more tailored and holistic approach to care. The study will compare the effectiveness of this enhanced collaborative care with traditional methods, focusing on patient and clinician satisfaction. By addressing the limitations of current CoCM practices, the trial seeks to improve treatment outcomes and patient motivation.
Why it matters
Potential benefit: If successful, this approach could lead to improved patient engagement and satisfaction in mental health care.
How similar studies have gone: Other studies have shown promise in enhancing patient engagement through personalized care approaches, making this a potentially impactful but not entirely novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients enrolled in the Collaborative Care Model (CoCM) at Dartmouth Health Exclusion Criteria: * Patients not enrolled in the Collaborative Care Model (CoCM) at Dartmouth Health
Where it's running
-
Dartmouth Hitchcock Concord Family Medicine
Concord, New Hampshire, United States Recruiting -
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States Recruiting -
Dartmouth-Hitchcock Heater Road Internal Medicine
Lebanon, New Hampshire, United States Recruiting -
Dartmouth Hitchcock Manchester Family Practice
Manchester, New Hampshire, United States Recruiting -
Dartmouth Hitchcock Nashua Family Practice
Nashua, New Hampshire, United States Recruiting -
Dartmouth Hitchcock Nashua General Internal Medicine
Nashua, New Hampshire, United States Recruiting
Study contacts
- Principal investigator: Anna Tosteson, ScD — Dartmouth College
- Study coordinator: Irina Perreard, PhD
- Email: irina.perreard@dartmouth.edu
- Phone: 603-646-5449
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Fluoxetine added to immunotherapy for advanced liver and gallbladder cancer with depression or anxiety
This trial will test whether adding the antidepressant fluoxetine to standard PD-1/PD-L1 immunotherapy helps people with advanced liver or gallbladder cancers who also have depression or anxiety.
-
AI-COA®: using AI to measure depression and anxiety severity from video interviews
This will test whether an AI tool can reliably measure depression and anxiety severity from video interviews in adults who have just started a new treatment.
-
Understanding anxiety, depression, and bipolar disorder over time in China
This study tests how anxiety, depressive, and bipolar symptoms change over three years to find patterns that help with earlier recognition and prediction in people aged 12–55.
-
See if personalized CBM-I can help anxious kids ages 10–17
Aimed at youth with Generalized, Separation, or Social Anxiety, the study tests a personalized cognitive bias modification for interpretation (CBM-I) to see if it reduces threat-focused thinking and anxiety.
-
Expectancy Focused Exposure for Anxiety Disorders
We test whether Expectancy Focused Exposure helps reduce anxiety symptoms and prevent fear from coming back better than Anxiety Focused Exposure in adults with anxiety disorders.
-
Does extra family income improve child mental health and brain biology in low-income families?
This study tests whether three years of extra income for parents can improve their child’s mental health and neuroimmune function.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.